Philip Meuleman

7.5k citations

121 papers · 5.4k indexed · 1 hit paper · h-index 43

Impact in

Hepatology top 0.1%
- Hepatitis C virus research
- Hepatitis Viruses Studies and Epidemiology
- Liver Disease and Transplantation
Epidemiology top 0.5%
- Hepatitis B Virus Studies
- Liver Disease Diagnosis and Treatment

Papers in

Hepatology 88
- Hepatitis C virus research 70
- Hepatitis Viruses Studies and Epidemiology 22
- Liver Disease and Transplantation 16
Epidemiology 70
- Hepatitis B Virus Studies 61
- Liver Disease Diagnosis and Treatment 34

Co-authors: Geert Leroux‐Roels Thomas Vanwolleghem Koen Vercauteren Isabelle Desombere Lieven Verhoye Ibrahim M. Sayed Louis Libbrecht Tania Roskams
Journals: Journal of Hepatology (11 papers)Hepatology (11 papers)Journal of Virology (11 papers)Antiviral Research (7 papers)Gut (6 papers)
Partner nations: Belgium Germany United States

In The Last Decade

Philip Meuleman

119 papers receiving 5.4k citations

Hit Papers

align trajectories log scale

Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro 2006 · 331 citations

Peers

Countries citing papers authored by Philip Meuleman

Since Specialization

Citations

This map shows the geographic impact of Philip Meuleman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip Meuleman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip Meuleman more than expected).

Fields of papers citing papers by Philip Meuleman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philip Meuleman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip Meuleman. The network helps show where Philip Meuleman may publish in the future.

Co-authors

The 25 scholars most cited alongside Philip Meuleman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Philip Meuleman Line = papers co-authored together Philip Meuleman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Higher Hepatitis E Seroprevalence in Workers in the Pig Sector in Flanders, Belgium: Results From a Seroprevalence Case‐Control Study Zoonoses and Public Health ·Heidi Janssens, Lies Delameillieure, Stijn Jonckheere, Freya Van Houtte, Philip Meuleman, Tom Geens	2025	1
2	IFN-β production promotes metabolic rewiring and protection against oxidative stress in hepatitis delta virus-infected hepatocyte cultures Cell Death and Disease ·Olga A. Khomich, Patrick Giavalisco, Romain Parent, George S. Krasnov, Peter Tessarz, Philip Meuleman, Rani Burm, Natalia F. Zakirova, Jennifer Molle, Enkhtuul Batbold, Eyal Gottlieb, Fabien Zoulim, Alexander V. Ivanov, Birke Bartosch	2025	0
3	A critical role for HNF4α in polymicrobial sepsis-associated metabolic reprogramming and death EMBO Molecular Medicine ·Céline Van Dender, Steven Timmermans, Ville Paakinaho, Tineke Vanderhaeghen, Jolien Vandewalle, Maarten Claes, Bruno Garcia, Bart I. Roman, Jan J. De Waele, Siska Croubels, Karolien De Bosscher, Philip Meuleman, Antoine Herpain, Jorma J. Palvimo, Claude Libert	2024	6
4	Preclinical animal models to evaluate therapeutic antiviral antibodies Antiviral Research ·Amse De Meyer, Philip Meuleman	2024	1
5	Novel prime-boost immune-based therapy inhibiting both hepatitis B and D virus infections Gut ·Rani Burm, Panagiota Maravelia, Gustaf Ahlén, Sandra Ciesek, Noelia Caro Pérez, Anna Pasetto, Stephan Urban, Freya Van Houtte, Lieven Verhoye, Heiner Wedemeyer, Magnus Johansson, Lars Frelin, Matti Sällberg, Philip Meuleman	2022	7
6	A ribavirin-induced ORF2 single-nucleotide variant produces defective hepatitis E virus particles with immune decoy function Proceedings of the National Academy of Sciences ·Toni Luise Meister, Yannick Brüggemann, Maximilian K. Nocke, Rainer G. Ulrich, Jonas Schuhenn, Kathrin Sutter, André Gömer, Verian Bader, Konstanze F. Winklhofer, Ruth Broering, Lieven Verhoye, Philip Meuleman, Florian W. R. Vondran, Charline Camuzet, Laurence Cocquerel, Daniel Tödt, Eike Steinmann	2022	12
7	A human monoclonal antibody against HBsAg for the prevention and treatment of chronic HBV and HDV infection JHEP Reports ·Rani Burm, Freya Van Houtte, Lieven Verhoye, Ahmed Atef Mesalam, Sandra Ciesek, Philippe Roingeard, Heiner Wedemeyer, Geert Leroux‐Roels, Philip Meuleman	2022	6
8	Functional Study of the C-Terminal Part of the Hepatitis C Virus E1 Ectodomain Journal of Virology ·Rehab I. Moustafa, Juliano G. Haddad, Lydia Linna, Xavier Hanoulle, Véronique Descamps, Ahmed Atef Mesalam, Thomas F. Baumert, Gilles Duverlie, Philip Meuleman, Jean Dubuisson, Muriel Lavie	2018	6
9	Hepatitis E virus lifecycle and identification of 3 forms of the ORF2 capsid protein Journal of Hepatology ·(unknown), Czeslaw Wychowski, Ibrahim M. Sayed, Jean‐Christophe Meunier, Jean‐Michel Saliou, Maliki Ankavay, A W Bull, André Pillez, Florence Abravanel, F. Helle, Étienne Brochot, Hervé Drobecq, R Farhat, Cécile‐Marie Aliouat‐Denis, Juliano G. Haddad, Jacques Izopet, Philip Meuleman, Anne Goffard, Jean Dubuisson, Laurence Cocquerel	2018	4
10	The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo Antiviral Research ·Daniel Tödt, Nora Moeller, Dimas Praditya, Volker Kinast, Martina Friesland, Michael Engelmann, Lieven Verhoye, Ibrahim M. Sayed, Patrick Behrendt, Viet Loan Dao Thi, Philip Meuleman, Eike Steinmann	2018	61
11	Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver Gut ·Ibrahim M. Sayed, Lieven Verhoye, Laurence Cocquerel, Florence Abravanel, Lander Foquet, (unknown), Yannick Debing, Ali Farhoudi, Czeslaw Wychowski, Jean Dubuisson, Geert Leroux‐Roels, Johan Neyts, Jacques Izopet, Thomas Michiels, Philip Meuleman	2016	106
12	Targeting a host-cell entry factor barricades antiviral-resistant HCV variants from on-therapy breakthrough in human-liver mice Gut ·Koen Vercauteren, Richard J. P. Brown, Ahmed Atef Mesalam, Juliane Doerrbecker, Sabin Bhuju, Robert Geffers, Naomi Van Den Eede, C. Patrick McClure, Fulvia Troise, Lieven Verhoye, Thomas F. Baumert, Ali Farhoudi, Riccardo Cortese, Jonathan K. Ball, Geert Leroux‐Roels, Thomas Pietschmann, Alfredo Nicosia, Philip Meuleman	2015	22
13	Host cell mTORC1 is required for HCV RNA replication Gut ·Stefanie Stöhr, Rui Costa, Lisa Sandmann, Sandra Westhaus, Stephanie Pfaender, Anggakusuma, Eva Dazert, Philip Meuleman, Florian W. R. Vondran, Michael P. Manns, Eike Steinmann, Thomas von Hahn, Sandra Ciesek	2015	41
14	Assessment of Parasite Liver-Stage Burden in Human-Liver Chimeric Mice Methods in molecular biology ·Lander Foquet, Philip Meuleman, Cornelus C. Hermsen, Robert W. Sauerwein, Geert Leroux‐Roels	2015	5
15	A Human Monoclonal Antibody Targeting Scavenger Receptor Class B Type I Precludes Hepatitis C Virus Infection and Viral Spread In Vitro and In Vivo Hepatology ·Philip Meuleman, Maria Teresa Catanese, Lieven Verhoye, Isabelle Desombere, Ali Farhoudi, Christopher T. Jones, Timothy P. Sheahan, Katarzyna Grzyb, Riccardo Cortese, Charles M. Rice, Geert Leroux‐Roels, Alfredo Nicosia	2011	112
16	Lipoprotein Lipase Inhibits Hepatitis C Virus (HCV) Infection by Blocking Virus Cell Entry PLoS ONE ·Patrick Maillard, Marine Walic, Philip Meuleman, Farzin Roohvand, Thierry Huby, Wilfried Le Goff, Geert Leroux‐Roels, Eve‐Isabelle Pécheur, Agata Budkowska	2011	42
17	Production of Infectious Genotype 1b Virus Particles in Cell Culture and Impairment by Replication Enhancing Mutations PLoS Pathogens ·Thomas Pietschmann, Margarita Zayas, Philip Meuleman, Gang Long, Nicole Appel, George Koutsoudakis, Stephanie Kallis, Geert Leroux‐Roels, Volker Lohmann, Ralf Bartenschlager	2009	107
18	Combination of liquid‐chromatography tandem mass spectrometry in different scan modes with human and chimeric mouse urine for the study of steroid metabolism Drug Testing and Analysis ·Óscar J. Pozo, Leen Lootens, Peter Van Eenoo, Koen Deventer, Philip Meuleman, Geert Leroux‐Roels, Maria Kristina Parr, Wilhelm Schänzer, F.T. Delbeke	2009	31
19	Steroid metabolism in chimeric mice with humanized liver Drug Testing and Analysis ·Leen Lootens, Peter Van Eenoo, Philip Meuleman, Óscar J. Pozo, Pieter Van Renterghem, Geert Leroux‐Roels, F.T. Delbeke	2009	20
20	Cell culture-grown hepatitis C virus is infectious in vivo and can be recultured in vitro Proceedings of the National Academy of Sciences ·Brett D. Lindenbach, Philip Meuleman, Alexander Ploß, Thomas Vanwolleghem, Andrew J. Syder, Jane A. McKeating, Robert E. Lanford, Stephen M. Feinstone, Marian Major, Geert Leroux‐Roels, Charles M. Rice Hit paper breakdown →	2006	331

About Philip Meuleman

Philip Meuleman is a scholar working on Hepatology, Epidemiology, Pharmacology, Infectious Diseases and Virology, having authored 121 papers that have together received 5.4k indexed citations. Recurring topics across this work include Hepatitis C virus research (70 papers), Hepatitis B Virus Studies (61 papers), Liver Disease Diagnosis and Treatment (34 papers), Hepatitis Viruses Studies and Epidemiology (22 papers), Liver Disease and Transplantation (16 papers), Viral gastroenteritis research and epidemiology (14 papers), Monoclonal and Polyclonal Antibodies Research (11 papers) and Hormonal and reproductive studies (9 papers). The work is most often cited by research in Hepatology (3.5k citations), Epidemiology (2.7k citations), Virology (366 citations), Infectious Diseases (823 citations) and Pharmacology (301 citations). Philip Meuleman has collaborated with scholars based in Belgium, Germany and United States. Frequent co-authors include Geert Leroux‐Roels, Thomas Vanwolleghem, Koen Vercauteren, Isabelle Desombere, Lieven Verhoye, Ibrahim M. Sayed, Louis Libbrecht, Tania Roskams, Jens Bukh and Charles M. Rice. Their work appears in journals such as Journal of Hepatology, Hepatology, Journal of Virology, Antiviral Research and Gut.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact